News
Bharat Biotech gearing up to conduct phase-1 trials for its new intranasal vaccine for Covid-19
Encouraged by the recent approval by Drug Control General of India (DCGI) for its Covid-19 vaccine, Bharat Biotech is now gearing up for conducting the...
Drug Research
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
Kite, a Gilead Company, and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies,...
News
Taysha, Catalent Partner to Advance Gene Therapies for Batten, Other Disorders
Taysha Gene Therapies announced that it has joined with Catalent, a pharmaceutical services provider, to support production of its potential gene therapies for disorders that...
Drug Research
WuXi STA’s Integrated CMC Platform Supports InnoCare Orelabrutinib Approved by NMPA
STA Pharmaceutical, a WuXi AppTec Company (WuXi STA), announces their partner Innocare has received approval by the National Medical Products Administration of China (NMPA) for...
News
Idifarma partners with industry expert to strengthen spray drying expertise
SPANISH contract development and manufacturing organisation (CDMO) Idifarma has announced a partnership with Stefano Console from Swiss life sciences consultancy Oriento SA.
Bringing with him the...
News
Sputnik V working to take AstraZeneca vaccine efficacy to over 90 per cent
With the Drug Controller General of India (DCGI) approving Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving way for...
News
Across International’s Ultra Low-Freezers (ULT) Can Distribute the COVID-19 Vaccine on Global Scale
As of now, the race to distribute and transport the COVID-19 vaccine has started. Simultaneously, the demand for ultra-low freezers is higher than ever. Ultra-low...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.